Compare Natera Inc. Common Stock (NTRA) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Energy Select Sector SPDR Fund — how do they compare? Natera Inc. Common Stock trades at $393.27 (market cap $57.03B), while Energy Select Sector SPDR Fund trades at $67.95 (market cap $43.83B). The key difference: Natera Inc. Common Stock is the larger of the two by market cap, and Energy Select Sector SPDR Fund is trading nearer its 52-week high, Natera Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Energy Select Sector SPDR Fund for 68 Days on average.
| NTRA | XLE | |
|---|---|---|
Market Cap | $57.03B | $43.83B |
Volume | 1,131,157 | 25,205,402 |
Sector | Health | — |
52-Week High | $425.64 | $67.61 |
52-Week Low | $179.42 | $42.64 |
Typical Hold Time | 0 Days | 68 Days |
Enterprise Value | $56.18B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
XLE trades at $67.17, up 1.74% today, with a bullish technical signal from moving averages and oscillators, though RSI levels suggest overbought conditions. Support and resistance levels are tightly clustered near the current price. Recent news highlights energy sector volatility driven by oil price swings and geopolitical tensions, with XLE offering broad energy exposure at low cost.
The outlook for XLE is influenced by oil market dynamics and Federal Reserve policy, presenting opportunity from rising energy prices but risk from potential oil price reversals. Investors should weigh the fund's narrow oil and gas focus against broader energy infrastructure alternatives for diversified income and lower volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
